Share This

Related Topics News - Drugs

     
 Detail   |   Print    Next page > 
     
《業績》白雲山首季純利18.21億元人民幣 按年跌7%
2025-04-29T  
四環醫藥回購1,617萬股 購買價1,089萬元
2025-04-28T  
金斯瑞斥2.25億美元增持CDMO服務附屬Probio Cayman
2025-04-28T  
新華製藥甲鈷胺片藥品補充申請獲批
2025-04-28T  
山東新華製藥阿司匹林腸溶片新增規格及通過仿製藥一致性評價
2025-04-28T  
《業績》山東新華製藥股份首季純利1.12億元人民幣跌21%
2025-04-28T  
金斯瑞生物科技甜味蛋白產品獲美國藥監局GRAS認證
2025-04-28T  
《大行》美銀證券升石藥目標價至5.1元 評級「跑輸大市」
2025-04-28T  
《業績》國藥首季賺14.57億人幣 按年升2.6%
2025-04-28T  
四環醫藥(00460.HK)聚乳酸面部填充劑獲國家藥監局上市批准
2025-04-27T  
  Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.